Identification of the von Hippel-Lindau disease tumor suppressor gene
- PMID: 8493574
- DOI: 10.1126/science.8493574
Identification of the von Hippel-Lindau disease tumor suppressor gene
Abstract
A gene discovered by positional cloning has been identified as the von Hippel-Lindau (VHL) disease tumor suppressor gene. A restriction fragment encompassing the gene showed rearrangements in 28 of 221 VHL kindreds. Eighteen of these rearrangements were due to deletions in the candidate gene, including three large nonoverlapping deletions. Intragenic mutations were detected in cell lines derived from VHL patients and from sporadic renal cell carcinomas. The VHL gene is evolutionarily conserved and encodes two widely expressed transcripts of approximately 6 and 6.5 kilobases. The partial sequence of the inferred gene product shows no homology to other proteins, except for an acidic repeat domain found in the procyclic surface membrane glycoprotein of Trypanosoma brucei.
Comment in
-
New tumor suppressor gene captured.Science. 1993 May 28;260(5112):1235. doi: 10.1126/science.8493563. Science. 1993. PMID: 8493563 No abstract available.
Similar articles
-
Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.Am J Hum Genet. 1994 Dec;55(6):1092-102. Am J Hum Genet. 1994. PMID: 7977367 Free PMC article.
-
Von Hippel-Lindau disease and sporadic renal cell carcinoma.Cancer Surv. 1995;25:219-32. Cancer Surv. 1995. PMID: 8718521 Review.
-
Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.Genes Chromosomes Cancer. 1998 Jul;22(3):200-9. doi: 10.1002/(sici)1098-2264(199807)22:3<200::aid-gcc5>3.0.co;2-#. Genes Chromosomes Cancer. 1998. PMID: 9624531
-
Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.Cancer Res. 2002 Jul 1;62(13):3803-11. Cancer Res. 2002. PMID: 12097293
-
Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer.JAMA. 1995 Feb 15;273(7):564-70. JAMA. 1995. PMID: 7837390 Review. No abstract available.
Cited by
-
MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours.Fam Cancer. 2014 Mar;13(1):121-5. doi: 10.1007/s10689-013-9666-3. Fam Cancer. 2014. PMID: 23743562
-
The Role of Elongin BC-Containing Ubiquitin Ligases.Front Oncol. 2012 Feb 3;2:10. doi: 10.3389/fonc.2012.00010. eCollection 2012. Front Oncol. 2012. PMID: 22649776 Free PMC article.
-
Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy.Acta Pharm Sin B. 2023 Nov;13(11):4341-4372. doi: 10.1016/j.apsb.2023.07.019. Epub 2023 Jul 22. Acta Pharm Sin B. 2023. PMID: 37969742 Free PMC article. Review.
-
Precision medicine from the renal cancer genome.Nat Rev Nephrol. 2016 Nov;12(11):655-666. doi: 10.1038/nrneph.2016.133. Epub 2016 Oct 3. Nat Rev Nephrol. 2016. PMID: 27694978 Review.
-
lncRNA PVT1 in the Pathogenesis and Clinical Management of Renal Cell Carcinoma.Biomolecules. 2021 Apr 29;11(5):664. doi: 10.3390/biom11050664. Biomolecules. 2021. PMID: 33947142 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials